California objects to 23andMe sale to former CEO, says it would skirt state privacy law
By Ron Leuty,
San Francisco Business Times
| 06. 16. 2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will review the deal.
In an objection filed in U.S. Bankruptcy Court in St. Louis, Bonta's team said the proposed structure of 23andMe's sale to a nonprofit formed by Wojcicki skirts a 2021 state law that would require consumers give their "separate and express" consent before their genetic data and biological samples are transferred or disclosed.
More than 20 states have opposed the sale process due to concerns that consumers' genetic information and other private data would be exposed to uses they didn't agree to when signing up for 23andMe's service. In 23andMe's home state of California, the Genetic Information Privacy Act of 2021 should empower consumers to give proactive approval to transfer their data, the filing states.
23andMe doesn't dispute that the law applies, according to the filing, but fears that compliance would be "too costly" because many Californians would...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...
